Nuvalent, Inc. - Class A Common Stock, $0.0001 par value per share (NUVL)

CUSIP: 670703107

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+1,254,263
Put/Call ratio
66%
SEC-reported price per share
$70.92
Indexed holders
203
Value change
+$85,199,077
Number of buys
100
Open additional details 1 more signal available
Number of sells
107
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
74,610,025

Security key

670703107

Report period

Q1 2025

Indexed institutions

203

Top holders

10

Ownership snapshot

Top reported holders of NUVL - Nuvalent, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
1/15
Latest evidence
31 Dec 2024
13F 13D/G 3/4/5 Lead comparable stake: 6.8% 14 rows are not safely comparable across share classes. 13D/G row: VANGUARD GROUP INC Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 6.8%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership Top 1
VANGUARD GROUP INC 6.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
6.8%
Reported 13D/G · 31 Dec 2024
$352,249,354
4,499,864 shares
— 31 Dec 2024
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
3/4/5
10%+ Owner
—
denominator unverified
$68,348,670
897,671 shares
— 02 Aug 2021
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$1,408,337,359
17,991,024 shares
— 31 Dec 2024
Paradigm Biocapital Advisors LP
13F
Company
13F
—
denominator unverified
$419,845,308
5,363,379 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$301,501,447
3,851,577 shares
— 31 Dec 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$205,091,800
2,619,977 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
203
Shares
71,880,102
Indexed holders
203
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 indexed holders
215
Q1 2025 indexed holders
203
Indexed holder difference
-12
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .